Literature DB >> 25251594

The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum.

Ana Laura Colín-González1, Marisol Maya-López1, José Pedraza-Chaverrí2, Syed F Ali3, Anahí Chavarría4, Abel Santamaría5.   

Abstract

3-Hydroxykynurenine (3-HK), an intermediate metabolite of the kynurenine pathway, has been largely hypothesized as a neurotoxic molecule contributing to neurodegeneration in several experimental and clinical conditions. Interestingly, the balance in literature points to a dual role of this molecule in the CNS: in vitro studies describe neurotoxic and/or antioxidant properties, whereas in vivo studies suggest a role of this metabolite as a weak neurotoxin. This work was designed to investigate, under different experimental conditions, whether or not 3-HK is toxic to cells, and if the redox activity exerted by this molecule modulates its actions in the rat striatum. In order to evaluate these effects, 3-HK was administered in vitro to isolated striatal slices, and in vivo to the striatum of rats. In striatal slices, 3-HK exerted a concentration- and time-dependent effect on lipid peroxidation, inducing both pro-oxidant actions at low (5-20) micromolar concentrations, and antioxidant activity at a higher concentration (100µM). Interestingly, while 3-HK was unable to induce mitochondrial dysfunction in slices, at the same range of concentrations it prevented the deleterious effects exerted by the neurotoxin and related metabolite quinolinic acid (QUIN), the mitochondrial toxin 3-nitropropionic acid, and the pro-oxidant compound iron sulfate. These protective actions were related to the stimulation of glutathione S-transferase (GST) and superoxide dismutase (SOD) activities. In addition, 3-HK stimulated the protein content of the transcription factor and antioxidant regulator Nrf2, and some of its related proteins. Accordingly, 3-HK, but not QUIN, exhibited reductive properties at high concentrations. The striatal tissue of animals infused with 3-HK exhibited moderate levels of lipid and protein oxidation at short times post-lesion (h), but these endpoints were substantially decreased at longer times (days). These effects were correlated with an early increase in glutathione reductase (GR) and GST activities. However, these changes were likely to be merely compensatory as 3-HK-infused animals did not display behavioral (rotation) alterations or morphological changes in their injected striata. Altogether, these findings suggest that, despite 3-HK might exert pro-oxidant actions under certain conditions, these changes serve to evoke a redox modulatory activity that, in turn, could decrease the risk of cell damage. In light of this evidence, 3-HK seems to be more a redox modulatory molecule than a neurotoxic metabolite.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antioxidant systems; Cell preservation; Kynurenine pathway; Oxidative stress; Redox activity

Mesh:

Substances:

Year:  2014        PMID: 25251594     DOI: 10.1016/j.brainres.2014.09.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Oleamide Reduces Mitochondrial Dysfunction and Toxicity in Rat Cortical Slices Through the Combined Action of Cannabinoid Receptors Activation and Induction of Antioxidant Activity.

Authors:  Carolina Y Reyes-Soto; Mariana Villaseca-Flores; Enid A Ovalle-Noguez; Jade Nava-Osorio; Sonia Galván-Arzate; Edgar Rangel-López; Marisol Maya-López; Socorro Retana-Márquez; Isaac Túnez; Alexey A Tinkov; Tao Ke; Michael Aschner; Abel Santamaría
Journal:  Neurotox Res       Date:  2022-09-07       Impact factor: 3.978

2.  Shufeng Jiedu capsules protect rats against LPS-induced acute lung injury via activating NRF2-associated antioxidant pathway.

Authors:  Qingwu Liao; Wenan Chen; Zhufeng Tong; Mingming Xue; Tianwen Gu; Ying Yuan; Zhenju Song; Zhengang Tao
Journal:  Histol Histopathol       Date:  2020-12-21       Impact factor: 2.303

3.  Antioxidant Properties of Kynurenines: Density Functional Theory Calculations.

Authors:  Aleksandr V Zhuravlev; Gennady A Zakharov; Boris F Shchegolev; Elena V Savvateeva-Popova
Journal:  PLoS Comput Biol       Date:  2016-11-18       Impact factor: 4.475

Review 4.  Major Developments in the Design of Inhibitors along the Kynurenine Pathway.

Authors:  Kelly R Jacobs; Gloria Castellano-Gonzalez; Gilles J Guillemin; David B Lovejoy
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 5.  Redox Properties of Tryptophan Metabolism and the Concept of Tryptophan Use in Pregnancy.

Authors:  Kang Xu; Hongnan Liu; Miaomiao Bai; Jing Gao; Xin Wu; Yulong Yin
Journal:  Int J Mol Sci       Date:  2017-07-24       Impact factor: 5.923

Review 6.  Inhibiting the kynurenine pathway in spinal cord injury: Multiple therapeutic potentials?

Authors:  Kelly R Jacobs; David B Lovejoy
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

7.  URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors.

Authors:  Karla Chavira-Ramos; Mario Orozco-Morales; Çimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2020-11-03       Impact factor: 3.911

8.  Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.

Authors:  Bernadett Tuka; Aliz Nyári; Edina Katalin Cseh; Tamás Körtési; Dániel Veréb; Ferenc Tömösi; Gábor Kecskeméti; Tamás Janáky; János Tajti; László Vécsei
Journal:  J Headache Pain       Date:  2021-06-25       Impact factor: 7.277

9.  Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine.

Authors:  C M Forrest; K McNair; M Pisar; O S Khalil; L G Darlington; T W Stone
Journal:  Neuroscience       Date:  2015-09-10       Impact factor: 3.590

Review 10.  Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders.

Authors:  Adrian Mor; Anna Tankiewicz-Kwedlo; Anna Krupa; Dariusz Pawlak
Journal:  Cells       Date:  2021-06-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.